Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

RARXRARX
6 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in RA PHARMACEUTICALS INC

As of its Q1 2020 13F, Baker Bros. Advisors held 2,093,839 shares of RARX (Ra Pharmaceuticals), worth $100.5M. Baker Bros. Advisors' 13F filings listed RARX from Q1 2019 to Q1 2020, 5 quarterly filings. RARX was 0.6% of Baker Bros. Advisors' reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$18.4M

Total Shares Change

-823,113

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2020-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2020-Q1
Unchanged
2.1M
0.0%
$100.5M0.6%—
0
2019-Q4
Decreased
2.1M
-10.7%
$98.3M0.5%—
0
2019-Q3
Increased
2.3M
+30.2%
$55.5M0.4%—
44
2019-Q2
Increased
1.8M
+118.9%
$54.2M0.4%—
57
2019-Q1
First report
823,113
-
$18.4M0.1%—
0

Other major holders of RARX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used